Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6844.5000 -139.00 (-1.99%)
NSE Jul 10, 2025 15:31 PM
Volume: 183.7K
 

logo
Divi's Laboratories Ltd.
24 Jul 2017
6844.50
-1.99%
buy
by HDFC Securities
HDFC Securities
Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter.
 
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022, 06:14AM